AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cervantes Corp Ltd

0.009

0.000

Volume:- -

Turnover:53.98K

Market Cap:17.19M

PE:-18.67

High:0.009

Open:0.009

Low:0.009

Close:0.009

52wk High:0.009

52wk Low:0.009

Shares:1.91B

Float Shares:836.00M

Volume Ratio:0.43

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.000

EPS(LYR):0.000

ROE:-16.17%

ROA:-7.57%

PB:4.97

PE(LYR):-18.67

Loading ...

Overview Company News Filings

CVS Health to Pay $36.5 Million in Multistate Insulin Overbilling Settlement

MT Newswires Live

CVS Stock And Inflation Trends Investors Should Watch Right Now

Simply Wall St.

CVS Health (CVS) Earnings Beat Puts Valuation Back In Focus

Simply Wall St.

CVS Health (CVS) Following GLP 1 Launch Faces A Fresh Valuation Test

Simply Wall St.

How Investors May Respond To CVS (CVS) Expanding GLP-1 Support And Virtual Chronic Care Services

Simply Wall St.

CVS Health (CVS) Stock Could Be 5.5% Undervalued as Restructuring Hopes Face a P/E Test

Simply Wall St.

CVS Health (CVS) Valuation Check After Restructuring Charges And Earnings Miss

Simply Wall St.

Is Expanded GLP-1 Coverage Through Caremark Altering The Investment Case For CVS Health (CVS)?

Simply Wall St.

CVS Health's Aetna Cuts Complex Claims Processing Time Over 20% With New AI Platform

MT Newswires Live

A Look At CVS Health (CVS) Valuation After Q1 Earnings Beat And Higher 2026 Guidance

Simply Wall St.

CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says

MT Newswires Live

Sector Update: Health Care

MT Newswires Live

GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.30 - $7.50, vs. FactSet Est of $7.16

MT Newswires Live

A Look At CVS Health (CVS) Valuation After Guidance Reaffirmation And Medicare Advantage Update

Simply Wall St.

CVS Health's Aetna Says 88% of Prior Authorization Volume Standardized

MT Newswires Live

Did Insulin-Settlement Tailwinds and Medicare Advantage Boosts Just Shift CVS Health's (CVS) Investment Narrative?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CVS.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CVS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CVS.AU\",,,,,undefined,":{"symbol":"CVS.AU","market":"AU","secType":"STK","nameCN":"Cervantes Corp Ltd","latestPrice":0.009,"timestamp":1791435600000,"preClose":0.009,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"Cervantes Corp Ltd","floatShares":835997011,"shares":1910000000,"eps":-0.000482,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-08 16:00:00 AEDT","open":0.009,"high":0.009,"low":0.009,"amount":53978.878479383005,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.000482,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.009,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":0.4288793926956469,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CVS.AU\",,,,,undefined,":{"symbol":"CVS.AU","floatShares":835997011,"roa":"-7.57%","roe":"-16.17%","lyrEps":-0.000482,"volumeRatio":0.4288793926956469,"shares":1910000000,"dividePrice":0,"high":0.009,"amplitude":0,"preClose":0.009,"low":0.009,"week52Low":0.009,"pbRate":"4.97","week52High":0.009,"institutionHeld":0,"latestPrice":0.009,"eps":-0.000482,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.000482,"open":0.009,"prevYearClose":0.009,"prevWeekClose":0.009,"prevMonthClose":0.009,"prevQuarterClose":0.009,"fiveDayClose":0.009,"twentyDayClose":0.009,"sixtyDayClose":0.009},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVS.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVS.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650979947","title":"CVS Health to Pay $36.5 Million in Multistate Insulin Overbilling Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2650979947","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650979947?lang=en_us&edition=fundamental","pubTime":"2026-07-10 02:27","pubTimestamp":1783621675,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) will pay $36.5 million to resolve allegations that it knowingly submitted false claims to MassHealth and other government healthcare programs by over-dispensing insulin pens and impro","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","RTH","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU0061475181.USD","BK4504","LU2433249047.HKD","LU1699723380.USD","BK4585","IE00BZ1G4Q59.USD","BK4581","LU1983299246.USD","BK4588","IE00B19Z3B42.SGD","LU0432979614.USD","LU1059921491.USD","LU0208291251.USD","LU2125909593.SGD","IE0002270589.USD","LU0162691827.USD","IE00BKVL7J92.USD","LU0070302665.USD","IHF","LU2125909247.SGD","LU0320765489.SGD","LU0211331839.USD","LU1923622614.USD","BK4550","IE00BSNM7G36.USD","LU0072461881.USD","LU0006061336.USD","CVS","LU1571399168.USD","CVS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649610589","title":"CVS Stock And Inflation Trends Investors Should Watch Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2649610589","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649610589?lang=en_us&edition=fundamental","pubTime":"2026-07-08 16:33","pubTimestamp":1783499616,"startTime":"0","endTime":"0","summary":"Inflation is no longer just about what you pay at the pump. With energy prices easing after the U.S. Iran ceasefire, attention is shifting to stickier costs like rent, medical care, and services, all while consumer inflation expectations climb and the Federal Reserve keeps markets guessing on rates. That mix can help some stocks and hurt others, depending on how closely their earnings are tied to these price trends. This article breaks down 3 stocks from our Inflation Momentum Stocks With Key...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-stock-and-inflation-trends-investors-should-watch-right","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-stock-and-inflation-trends-investors-should-watch-right","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CGUI","CGDV","REGL","EQRR","PRVS","IUS","ADPV","RHTX","BAMA","RULE","ISBC","VXZ","ARP","DIVZ","PPTY","DFUV","ILCV","HIDV","CLIX","LCG","BKDV","FT","EES","BSR","FLV","CVS.AU","FXD","MDLV","VOTE","LGH","PSC","VTV","SDOG","AVB","XOEX","MODL","MAPP","IHF","NURE","KR","DECU","IMCG","RMIF","CVS","SAMT","TEQI","CDC","CGUS","RTH","RITA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649609833","title":"CVS Health (CVS) Earnings Beat Puts Valuation Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2649609833","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649609833?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:30","pubTimestamp":1783395056,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) is back in the spotlight after reporting quarterly earnings that surpassed expectations and lifting its full year profit outlook, with renewed investor attention also linked to commentary from Jim Cramer.\nSee our latest analysis for CVS Health.\nDespite a small pullback in the latest session, with the 1 day share price return declining 2.52% to close at US$102.08, CVS Health has seen momentum build over recent months. The 30 day share price return is 6.41% and the 90 day share...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-earnings-beat-puts-valuation-back-in-focus","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-earnings-beat-puts-valuation-back-in-focus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CVS.AU","CVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647099588","title":"CVS Health (CVS) Following GLP 1 Launch Faces A Fresh Valuation Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2647099588","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647099588?lang=en_us&edition=fundamental","pubTime":"2026-06-30 07:16","pubTimestamp":1782774963,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) has drawn fresh attention after launching a GLP-1 weight loss program that combines virtual consultations with access to these medicines, prompting analysts to reassess the company’s earnings potential and managed care exposure.\nSee our latest analysis for CVS Health.\nAt a share price of US$103.58, CVS Health has seen momentum build recently, with a 30 day share price return of 13.85% and a 90 day share price return of 44.22%. The 1 year total shareholder return of 55.65%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-following-glp-1-launch-faces-a-fresh-valuatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-following-glp-1-launch-faces-a-fresh-valuatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765489.SGD","LU1059921491.USD","LU0006061336.USD","IE00BSNM7G36.USD","CVS","GLP","BK4144","LU1571399168.USD","LU0061475181.USD","IE00B19Z3581.USD","LU1983299246.USD","IE0002270589.USD","LU0432979614.USD","BK4550","BK4585","CVS.AU","LU0162691827.USD","LU0070302665.USD","BK4588","BK4581","IE00B7SZLL34.SGD","LU1923622614.USD","LU2125909593.SGD","LU0072461881.USD","LU0211331839.USD","BK4590","LU2433249047.HKD","LU2125909247.SGD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU1699723380.USD","BK4504","IE00BKVL7J92.USD","LU0208291251.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645830821","title":"How Investors May Respond To CVS (CVS) Expanding GLP-1 Support And Virtual Chronic Care Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2645830821","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645830821?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:28","pubTimestamp":1782224921,"startTime":"0","endTime":"0","summary":"In recent weeks, CVS Health has expanded its support for GLP-1 medications through new $49 MinuteClinic virtual evaluations, enhanced pharmacy guidance, and participation from July 1, 2026 in the Medicare GLP-1 Bridge program, while also advancing automation, AI-enabled health platforms, sustainability initiatives, and community health partnerships.\nThese moves highlight CVS Health's push to deepen its role in chronic disease management and tech-enabled care, potentially reinforcing its...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/how-investors-may-respond-to-cvs-cvs-expanding-glp-1-support","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/how-investors-may-respond-to-cvs-cvs-expanding-glp-1-support","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0162691827.USD","BK4144","BK4550","LU1699723380.USD","LU1059921491.USD","IE00B19Z3581.USD","LU0432979614.USD","LU1571399168.USD","BK4504","CVS","GLP","ISBC","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0006061336.USD","LU0211331839.USD","LU2125909593.SGD","BK4581","BK4211","LU0072461881.USD","CVS.AU","LU0061475181.USD","LU1983299246.USD","LU0070302665.USD","LU2433249047.HKD","ARTY","IE0002270589.USD","AGIX","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","BK4196","BK4588","AIPO","BK4585","IE00BZ1G4Q59.USD","BK4590","LU0208291251.USD","LU1923622614.USD","LU0320765489.SGD","LU2125909247.SGD","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645290130","title":"CVS Health (CVS) Stock Could Be 5.5% Undervalued as Restructuring Hopes Face a P/E Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2645290130","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645290130?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:21","pubTimestamp":1782123679,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) is drawing investor attention after recent trading left the stock around $98.32, with performance over the past month and past 3 months contrasting with short term weekly declines.\nSee our latest analysis for CVS Health.\nShort term momentum for CVS Health has eased, with the share price declining 0.85% over the last day and 2.34% over the week. However, the 90 day share price return of 35.05% and 1 year total shareholder return of 52.55% point to a much stronger recent run...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-stock-could-be-55-undervalued-as-restructurin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-stock-could-be-55-undervalued-as-restructurin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2125909247.SGD","LU0061475181.USD","LU1059921491.USD","IE00B19Z3581.USD","LU2125909593.SGD","LU1699723380.USD","IE00B7SZLL34.SGD","LU0162691827.USD","BK4588","LU1571399168.USD","CVS","LU0320765489.SGD","LU2433249047.HKD","IE0002270589.USD","BK4550","BK4581","BK4585","LU0432979614.USD","LU0072461881.USD","IE00BSNM7G36.USD","BK4196","LU1923622614.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0006061336.USD","LU1983299246.USD","LU0211331839.USD","CVS.AU","BK4504","LU0070302665.USD","LU0208291251.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641125253","title":"CVS Health (CVS) Valuation Check After Restructuring Charges And Earnings Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2641125253","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641125253?lang=en_us&edition=fundamental","pubTime":"2026-06-06 09:19","pubTimestamp":1780708789,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) has drawn fresh attention after recent share price gains, with the stock up about 11.7% over the past week and roughly 10.4% over the past month. This has prompted closer scrutiny from investors.\nSee our latest analysis for CVS Health.\nThose short term gains sit within a stronger run, with a 90 day share price return of 23.11% and a 1 year total shareholder return of 56.40%, suggesting momentum has been building.\nIf recent gains in healthcare catch your attention, it could be...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-valuation-check-after-restructuring-charges-a","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-cvs-valuation-check-after-restructuring-charges-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CVS","CVS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640118089","title":"Is Expanded GLP-1 Coverage Through Caremark Altering The Investment Case For CVS Health (CVS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640118089","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640118089?lang=en_us&edition=fundamental","pubTime":"2026-06-02 16:24","pubTimestamp":1780388672,"startTime":"0","endTime":"0","summary":"In late May 2026, CVS Health announced past updates to its CVS Caremark commercial formularies, reintroducing Zepbound (tirzepatide) as a preferred GLP-1 option from October 1, 2026, and lifting the new-to-market block on the oral GLP-1 Foundayo (orforglipron) for plans that approve coverage.\nBy broadening access to GLP-1 weight management drugs while emphasizing affordability for plan sponsors, CVS Health is reinforcing its role as a pharmacy benefits manager focused on cost control and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-expanded-glp-1-coverage-through-caremark-altering-the-inv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-expanded-glp-1-coverage-through-caremark-altering-the-inv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1059921491.USD","LU0072461881.USD","IE00BZ1G4Q59.USD","LU2433249047.HKD","BK4543","AI","BK4196","CHAT","LU2125909593.SGD","AIPO","LU1571399168.USD","CVS.AU","IE00BKVL7J92.USD","CVS","LU0211331839.USD","GLP","ARTY","LU0320765489.SGD","LU0432979614.USD","IE00B19Z3581.USD","IE0002270589.USD","AIYY","LU0006061336.USD","BK4144","LU0070302665.USD","AGIX","LU0162691827.USD","BK4585","LU0208291251.USD","LU2125909247.SGD","BK4590","LU1923622614.USD","BK4587","IE00BSNM7G36.USD","BK4551","IE00B7SZLL34.SGD","BK4504","BK4588","IE00B19Z3B42.SGD","LU1983299246.USD","BK4550","LU1699723380.USD","BK4581","LU0061475181.USD","BK4528","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638107565","title":"CVS Health's Aetna Cuts Complex Claims Processing Time Over 20% With New AI Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2638107565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638107565?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:48","pubTimestamp":1779803311,"startTime":"0","endTime":"0","summary":"CVS Health's  Aetna unit has cut claims processing times by more than 20% for complex claims that require manual review, using a new AI-powered platform designed to improve accuracy and accelerate payments, the company said Tuesday.The second-generation Aetna Claims Assist Manager integrates eligibility, coverage, member and provider data to automate complex claims workflows, recommend next-best actions, and reduce manual review steps, the company added.Price: 92.25, Change: -1.03, Percent Change: -1.10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0432979614.USD","ARTY","IE00B19Z3B42.SGD","LU0006061336.USD","CVS.AU","IE00B19Z3581.USD","BK4504","AET","BK4588","CVS","IE00BKVL7J92.USD","IE0002270589.USD","BK4585","IE00B7SZLL34.SGD","LU0320765489.SGD","AGIX","IE00BSNM7G36.USD","BK4581","LU2125909247.SGD","LU1059921491.USD","LU1571399168.USD","LU1983299246.USD","LU2433249047.HKD","LU0072461881.USD","IE00BZ1G4Q59.USD","BK4196","BK4550","AIPO","CHAT","LU1923622614.USD","LU0061475181.USD","LU1699723380.USD","LU0211331839.USD","LU0208291251.USD","LU0070302665.USD","LU0162691827.USD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634475018","title":"A Look At CVS Health (CVS) Valuation After Q1 Earnings Beat And Higher 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2634475018","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634475018?lang=en_us&edition=fundamental","pubTime":"2026-05-11 10:14","pubTimestamp":1778465679,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) delivered first quarter 2026 earnings that came in ahead of expectations across all segments. This prompted higher full year earnings guidance and fresh attention on its pharmacy, insurance and technology plans.\nSee our latest analysis for CVS Health.\nThe 1-month share price return of 11.68% and 90-day share price return of 11.50% suggest momentum has picked up around the recent earnings beat and raised guidance. The 1-year total shareholder return of 33.46% points to a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-q1-earnings-beat-an","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-q1-earnings-beat-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CVS.AU","CVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633124246","title":"CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2633124246","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633124246?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:15","pubTimestamp":1778170527,"startTime":"0","endTime":"0","summary":"CVS Health  is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings \"comfortably\" beat expectations, driven by \"strong\" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: 87.01, Change: +0.14, Percent Change: +0.17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0432979614.USD","IE00B19Z3B42.SGD","LU0006061336.USD","CVS.AU","IE00B19Z3581.USD","BK4504","BK4588","CVS","IE00BKVL7J92.USD","IE0002270589.USD","BK4585","IE00B7SZLL34.SGD","LU0320765489.SGD","IE00BSNM7G36.USD","BK4581","LU1059921491.USD","LU1571399168.USD","LU1983299246.USD","LU0072461881.USD","IE00BZ1G4Q59.USD","BK4196","BK4550","LU0061475181.USD","LU1699723380.USD","LU0211331839.USD","LU0208291251.USD","LU0070302665.USD","LU0162691827.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633158665","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2633158665","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633158665?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:08","pubTimestamp":1778087291,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF  shedding 0.2%.The iShares Biotechnology ETF  climbed 1.7%.In corporate news, CVS Health  raised its full-year earnings outlook after reporting better-than-expected Q1 results driven by improvement in its health-care benefits segment. Its shares gained 6.7%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BKVL7J92.USD","LU1699723380.USD","BK4550","IE0002270589.USD","LU0061475181.USD","BK4196","CVS","IE00BSNM7G36.USD","BK4588","BK4504","IBB","IE00B7SZLL34.SGD","LU0208291251.USD","BK4585","IE00B19Z3B42.SGD","LU1983299246.USD","XLV","LU0072461881.USD","IE00BZ1G4Q59.USD","LABU","LU0162691827.USD","LU0211331839.USD","CVS.AU","LU1059921491.USD","XBI","LU0320765489.SGD","LU1571399168.USD","BK4581","LU0070302665.USD","LU0432979614.USD","LU0006061336.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633818961","title":"GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.30 - $7.50, vs. FactSet Est of $7.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2633818961","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633818961?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:34","pubTimestamp":1778063678,"startTime":"0","endTime":"0","summary":"GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.30 - $7.50, vs. FactSet Est of $7.16","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CVS.AU","CVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632609144","title":"A Look At CVS Health (CVS) Valuation After Guidance Reaffirmation And Medicare Advantage Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2632609144","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632609144?lang=en_us&edition=fundamental","pubTime":"2026-05-03 13:32","pubTimestamp":1777786343,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) is back in focus after reaffirming its earnings guidance and outlining plans to improve Aetna margins, as investors digest a higher than expected 2027 Medicare Advantage payment update and easing regulatory questions around insulin pricing.\nSee our latest analysis for CVS Health.\nThe reaffirmed earnings outlook and support for Aetna margins have arrived alongside a 30 day share price return of 11.7% and a 1 year total shareholder return of 26.1%. This suggests recent momentum...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-guidance-reaffirmat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-guidance-reaffirmat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0432979614.USD","IE0002270589.USD","LU1699723380.USD","BK4504","LU0070302665.USD","IE00BKVL7J92.USD","BK4581","CVS.AU","CVS","LU1571399168.USD","BK4550","LU0006061336.USD","LU0061475181.USD","IE00BSNM7G36.USD","LU0072461881.USD","BK4196","IE00B19Z3581.USD","BK4588","LU0320765489.SGD","LU1059921491.USD","LU0162691827.USD","LU0208291251.USD","BK4585","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU0211331839.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842902","title":"CVS Health's Aetna Says 88% of Prior Authorization Volume Standardized","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842902","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842902?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:31","pubTimestamp":1777037498,"startTime":"0","endTime":"0","summary":"CVS Health's  Aetna said Friday it has standardized 88% of its prior authorization volume, exceeding industry commitments.The company said it has approved more than 95% of eligible prior authorizations within 24 hours, with 83% processed in real time, exceeding America's Health Insurance Plans' goal of 80% by 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0208291251.USD","LU1571399168.USD","BK4585","LU0162691827.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4550","LU0061475181.USD","LU0070302665.USD","LU1699723380.USD","AET","CVS","LU1983299246.USD","LU0320765489.SGD","LU0211331839.USD","BK4581","BK4196","IE00B7SZLL34.SGD","CVS.AU","IE00BSNM7G36.USD","IE0002270589.USD","LU0006061336.USD","LU1059921491.USD","LU0072461881.USD","IE00BZ1G4Q59.USD","BK4588","BK4504","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629774290","title":"Did Insulin-Settlement Tailwinds and Medicare Advantage Boosts Just Shift CVS Health's (CVS) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629774290","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629774290?lang=en_us&edition=fundamental","pubTime":"2026-04-21 06:06","pubTimestamp":1776722772,"startTime":"0","endTime":"0","summary":"In mid-April 2026, analysts at UBS, Baird, and others reiterated positive views on CVS Health following its FTC insulin-pricing settlement and discussion of benefits from higher Medicare Advantage payments, even as more than 500 unionized workers at a Fredericksburg, Virginia distribution center authorized a strike that could disrupt Mid-Atlantic operations.\nAetna’s more than US$2.60 billion year-over-year adjusted operating income improvement and expectations for pharmacy benefit management...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-insulin-settlement-tailwinds-and-medicare-advantage-boos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-insulin-settlement-tailwinds-and-medicare-advantage-boos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0208291251.USD","LU1571399168.USD","BK4585","LU0162691827.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4550","LU0061475181.USD","LU0070302665.USD","LU1699723380.USD","CVS","LU1983299246.USD","LU0320765489.SGD","LU0211331839.USD","BK4581","BK4196","IE00B7SZLL34.SGD","CVS.AU","IE00BSNM7G36.USD","IE0002270589.USD","LU0006061336.USD","LU1059921491.USD","LU0072461881.USD","IE00BZ1G4Q59.USD","BK4588","BK4504","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}